Nicholas Robert, MD, Oncology, Fairfax, VA, Inova Alexandria Hospital

NicholasJRobertMD

Oncology Fairfax, VA

Breast Cancer, Hematologic Oncology

Virginia Cancer Specialists

Dr. Robert is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Robert's full profile

Already have an account?

Education & Training

  • Dana-Farber Cancer InstituteFellowship, Medical Oncology, 1980 - 1981
  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Hematology, 1979 - 1980
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Anatomic and Clinical Pathology, 1976 - 1978
  • McGill University Faculty of Medicine
    McGill University Faculty of MedicineClass of 1974

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 1991 - 2020
  • American Board of Pathology Anatomic Pathology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Top Doctors:Washington-Baltimore Castle Connolly, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Treatment Patterns and Outcomes of Patients with Relapsed or Refractory Follicular Lymphoma Treated with Idelalisib in a Community Oncology Setting
    Nicholas James Robert, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • Investigators from the US Oncology Network, US Oncology Research and McKesson Present More Than 60 Research Abstracts During the 2019 American Society of Clinical Oncology Annual Meeting
    Investigators from the US Oncology Network, US Oncology Research and McKesson Present More Than 60 Research Abstracts During the 2019 American Society of Clinical Oncology Annual MeetingMay 31, 2019 00:43
  • Real-World Evidence from McKesson Supports First-Ever FDA Approval for Metastatic Merkel Cell Carcinoma Drug
    Real-World Evidence from McKesson Supports First-Ever FDA Approval for Metastatic Merkel Cell Carcinoma DrugMay 16, 2018 18:12
  • McKesson Specialty Health and the US Oncology Network Invited to Participate in the Final
    McKesson Specialty Health and the US Oncology Network Invited to Participate in the FinalJanuary 12, 2017 11:06
  • Join now to see all

Hospital Affiliations